(Q43680826)

25 November 2017

Influence of vitamin E and C supplementation on lipoprotein oxidation in patients with Alzheimer's disease (English)

1 reference

25 November 2017

0 references

1 reference

Kontush A

1

1 reference

25 November 2017

Mann U

2

1 reference

25 November 2017

Arlt S

3

1 reference

25 November 2017

Ujeyl A

4

1 reference

25 November 2017

Lührs C

5

1 reference

25 November 2017

Müller-Thomsen T

6

1 reference

25 November 2017

Beisiegel U

7

1 reference

25 November 2017

1 August 2001

1 reference

Free Radical Biology and Medicine

25 November 2017

1 reference

25 November 2017

31

1 reference

25 November 2017

3

1 reference

25 November 2017

345-354

1 reference

Amyloid, the presenilins and Alzheimer's disease

25 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Amyloid beta-peptide and oxidative cellular injury in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Oxidative stress hypothesis in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Reactive oxygen species and Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Vitamin Homeostasis in the Central Nervous System

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Metals and neuroscience.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Early AGEing and Alzheimer's.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Cerebrospinal fluid trace element content in dementia: clinical, radiologic, and pathologic correlations.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Iron and aluminium in relation to brain ferritin in normal individuals and Alzheimer's-disease and chronic renal-dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

A controlled trial of selegiline, alpha-tocopherol, or both as treatment for Alzheimer's disease. The Alzheimer's Disease Cooperative Study.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Graded dietary levels of RRR-gamma-tocopherol induce a marked increase in the concentrations of alpha- and gamma-tocopherol in nervous tissues, heart, liver and muscle of vitamin-E-deficient rats.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Effect of dietary vitamin E and selenium on susceptibility of brain regions to lipid peroxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Vitamin E protects nerve cells from amyloid beta protein toxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Increased lipoprotein oxidation in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Time-course of oxidation of lipids in human cerebrospinal fluid in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Cerebrospinal fluid lipoproteins are more vulnerable to oxidation in Alzheimer's disease and are neurotoxic when oxidized ex vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Coantioxidants make alpha-tocopherol an efficient antioxidant for low-density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Biochemical characterization of Alzheimer's soluble amyloid beta protein in human cerebrospinal fluid: association with high density lipoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Lipoproteins in the central nervous system

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

High-performance liquid chromatography-coulometric electrochemical detection of ubiquinol 10, ubiquinone 10, carotenoids, and tocopherols in neonatal plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

How different constituents of human plasma and low density lipoprotein determine plasma oxidizability by copper

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Azodipyrroles of unconjugated and conjugated bilirubin using diazotized ethyl anthranilate in dimethyl sulfoxide

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Measurement of antioxidants in human blood plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Alpha-tocopherol as a reductant for Cu(II) in human lipoproteins. Triggering role in the initiation of lipoprotein oxidation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Continuous monitoring of in vitro oxidation of human low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Analysis of lipoprotein diene formation in human serum exposed to copper

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Measurement of oxidizability of blood plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Lipophilic antioxidants in blood plasma as markers of atherosclerosis: the role of alpha-carotene and gamma-tocopherol

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Apolipoprotein E-containing high density lipoprotein promotes neurite outgrowth and is a ligand for the low density lipoprotein receptor-related protein

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Oxidized lipoproteins may play a role in neuronal cell death in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

The effect of ascorbate and ubiquinone supplementation on plasma and CSF total antioxidant capacity.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Ascorbate is an outstanding antioxidant in human blood plasma

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Prevention of tocopherol-mediated peroxidation in ubiquinol-10-free human low density lipoprotein.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

Cosupplementation with coenzyme Q prevents the prooxidant effect of alpha-tocopherol and increases the resistance of LDL to transition metal-dependent oxidation initiation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5849%2801%2900595-0

7 January 2021

10.1016/S0891-5849(01)00595-0

Identifiers

DOI

1 reference

25 November 2017

1 reference